Oxitan contains Oxaliplatin, a platinum-based antineoplastic medicine used as part of combination chemotherapy for the treatment of several solid tumors, particularly colorectal cancer.

Oxaliplatin works by forming platinum-DNA complexes that cause DNA cross-linking and interfere with DNA replication and transcription. This can inhibit the growth and survival of susceptible cancer cells.

Oxaliplatin is generally administered intravenously as part of a combination chemotherapy regimen, commonly with fluoropyrimidine-based therapy such as 5-fluorouracil and leucovorin.

What is Oxaliplatin?

Oxaliplatin is a platinum-based cytotoxic chemotherapy agent. It damages cancer-cell DNA through platinum-mediated cross-linking, preventing malignant cells from properly replicating and dividing.

It is an important component of chemotherapy regimens used for colorectal and selected other gastrointestinal cancers.

Benefits / Uses

Oxitan (Oxaliplatin) may be used as part of treatment protocols for:

• Colorectal cancer
• Colon cancer
• Rectal cancer
• Advanced or metastatic colorectal cancer
• Selected gastrointestinal malignancies according to specialist oncology protocols

Oxaliplatin is frequently used in combination regimens such as FOLFOX.

Dosage Guidelines

Oxaliplatin dosage depends on the cancer type, treatment regimen, body surface area, organ function, previous treatment, and clinical response.

• Administer only under specialist oncology supervision.
• Oxaliplatin is administered by intravenous infusion.
• Blood counts should be monitored before and during treatment.
• Renal and hepatic function may be assessed as clinically appropriate.
• Neurological symptoms should be monitored, particularly peripheral sensory neuropathy.
• Dose modification or treatment interruption may be necessary for significant toxicity.
• Oxaliplatin should not be mixed or administered with incompatible solutions or medicines; preparation and administration should follow the approved product instructions.

Wholesale & Supply

Oxitan (Oxaliplatin) may be supplied for pharmaceutical wholesale and institutional procurement, subject to applicable regulatory requirements and destination-country regulations.

Bulk procurement enquiries may include:

• Available strengths and presentations
• Packaging configuration
• Certificate of Analysis (CoA)
• Batch information
• Manufacturing documentation
• Export and shipping documentation

Buying Online

Oxaliplatin is a prescription injectable chemotherapy medicine and should be sourced through authorized pharmaceutical distributors, hospitals, or licensed healthcare channels.

Reviews

Individual responses to Oxaliplatin can vary according to cancer type, disease stage, chemotherapy combination, dose, and patient-specific factors. Treatment response and tolerability should be evaluated by the treating oncology team.

Quality Assurance

Oxaliplatin products should undergo appropriate pharmaceutical quality-control testing according to applicable standards, including relevant testing for identity, potency, purity, sterility, and other formulation-specific quality requirements.

Frequently Asked Questions

What is Oxitan used for?

Oxitan contains Oxaliplatin and is primarily used as part of combination chemotherapy for colorectal cancer and selected other gastrointestinal malignancies.

What type of medicine is Oxaliplatin?

Oxaliplatin is a platinum-based cytotoxic chemotherapy medicine.

How does Oxaliplatin work?

Oxaliplatin forms platinum-DNA complexes and cross-links DNA, interfering with DNA replication and transcription in susceptible cancer cells.

How is Oxitan administered?

Oxitan is administered by intravenous infusion under the supervision of qualified healthcare professionals.

Is Oxaliplatin used with other chemotherapy medicines?

Yes. Oxaliplatin is commonly combined with medicines such as 5-fluorouracil and leucovorin in regimens including FOLFOX.

What are the important side effects of Oxaliplatin?

Common or clinically important adverse effects may include peripheral sensory neuropathy, nausea, vomiting, diarrhea, fatigue, and reduced blood-cell counts. Hypersensitivity reactions can also occur.

What is distinctive about Oxaliplatin-related neuropathy?

Oxaliplatin can cause acute cold-triggered sensory symptoms as well as cumulative peripheral neuropathy. Patients should report persistent or worsening neurological symptoms to their oncology team.

Does Oxaliplatin require laboratory monitoring?

Yes. Blood counts and relevant organ-function tests are generally monitored during treatment, according to the chemotherapy protocol.

Who should administer Oxitan?

Oxitan should be prescribed and administered by qualified healthcare professionals experienced in cancer chemotherapy.

Conclusion

Oxitan (Oxaliplatin) is a platinum-based cytotoxic chemotherapy medicine with an important role in the treatment of colorectal cancer, particularly in combination regimens such as FOLFOX. It works by damaging cancer-cell DNA and interfering with cellular replication. Because Oxaliplatin can cause significant hematological, gastrointestinal, neurological, and hypersensitivity-related toxicities, treatment requires specialist supervision and appropriate monitoring.